FindTrial
Sign In

A study on vitiligo to correlate the pathology findings in skin of vitiligo patients and the immune status of lesions of vitiligo skin.

A DESCRIPTIVE STUDY ON CLINICAL EVALUATION OF STABILITY OF VITILIGO AND ITS CORRELATION WITH DERMOSCOPY AND HISTOPATHOLOGY WITH EMPHASIS ON CELLULAR STABILITY BY IMMUNOHISTOCHEMISTRY USING CD4 CD8 COUNTS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/03/031817
Enrollment
30
Registered
2021-03-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

None listed

Sponsors

Indian Association Of Dermatologists Venereologists And Leprologists
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of age above 18 years and any sex with clinically diagnosed cases of vitiligo.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
The dermoscopic findings of lesional and marginal skin is correlated with histoptahologcal findings and IHC findings. If the findings of dermoscopy , histopathology and immunohistochemistry show consistent findings , Through this we will be able to offer the patients with stable vitiligo earlier surgical management at end of 6 months.Timepoint: 6 months—

Secondary

MeasureTime frame
The dermoscopic findings of lesional and marginal skin is correlated with histoptahologcal findings and IHC findings. If the findings of dermoscopy , histopathology and immunohistochemistry show consistent findings , Through this we will be able to offer the patients with stable vitiligo earlier surgical management .Timepoint: 1 year—

Countries

India

Contacts

Public ContactMadhurya santosh

Rajarajeswari medical college and hospital

drbelliappa@gmail.com9449664666

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026